Latest Feature Article
Illuminating Rare Disease
Bringing to light the challenges and hopes for the rare disease community
Bringing to light the challenges and hopes for the rare disease community
Genomic luminaries Drs. Marc Lalande and Kamran Shazand establish the Genomics Institute
Talking diagnostic odysseys, perseverance, and overcoming failure
Inside a model public health lab paving the way with genomic sequencing
Studies from Japan and Belgium seek to advance precision medicine in oncology
Date | Publication | Title |
---|---|---|
Mar 5, 2021 | GenomeWeb | Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents |
Mar 5, 2021 | ClinicalOMICs | Illumina Granted Registration in Russia for Clinical NGS Platform, Reagents |
Mar 4, 2021 | Tele Z (Switzerland) | Wie Entstehen Coronavirus-Mutationen? |
Feb 26, 2021 | Investor's Business Daily | Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning |
Feb 25, 2021 | BioPharma Reporter | German program using whole genome sequencing to diagnose rare diseases and cancer risk |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.